Collateral Valuation - Summary SlocA Price Assumptioias us of: 4-Sep-01 I EO1T $19.99 I3iiromi S35.00 TCW - Select $15.25 I Compaq SI 1.08 TCW - Aggr. $11.44 Eli Lilly S7S.72 TCW - Small $17.60 I BA I Compass I I Tolal 80 0% 80.0% 70.0% Original LOC Outstanding Current i;rv Mkt Val. Collateral Collateral Req. Excess (Delicit) Ilorrowlog l'owerl Pnroii Compaq Eli Lilly EOU TCW SI 0,000.000 $6,973,000 84.9% $8,217,695 ($498,555) $1,000,000 $670,000 76.6% $875,000 $837500 $37,500 S2 ,000,000 $2,190,352 62.4% $3,512,587 163,366 $13,000,000 $9,833,352 S 12,605,282 $9. 51L159 ($297,689) (5498,555)1 $30,000 I I6~,3~6 I ($3O~,tS9)I 100.0% 100.0% IOU (110904 818120(12 [TV A/P KLL Total all $2,523,500 S12,35,852 C -, u~. a. ~. ce. 0< 0'~I at" N. Allocation of (~o1lateral hA Corn ass FU 25.6% 100.0% 15.2% 00% 19.4% 0.0% diversified 1.2% 0.0% 38.6% 0.0% Collateral Valuation - Sututnaty Stock Price Assumpliosas as of: 4-Sep-01 Enron $35.00 Co.nptq $11.08 Eli Lilly $78.72 BA I Chase I Compass * I LTV ()rigisnal LOC (Jul si amadang Curi east i;iV Mki Val Collaicial Collaicral Req. Excess (Ijelicil) 80.0% 80.0% $40,000,000 $l5,000.000 $5,579,392 $2,689,000 48.1% $Il,606,971 $6.974.240 $4,632,731 82.9% $3,242,940 $3.36 1.250 ($118,310) 80.0% S tO ,000,000 $3,489,871 54.8% $6,370,330 $3 .296.264 Eli I Tolal III loan 70.0% 80.0% $10,083,697 $2l,841,960 73.1% $13,800,000 $J5,020,2'l I $13.63 1.754 $4,514,421 ~5,000,000 74.0% 56,759,550 509,550 Borrowlaug i'owerl S~,7Q6~I~5 I .($~J~p,4.lQ)I . ($l93,~jQ7)I *I~ 53394,2681 .............1 _________________ Outsiaanding $750,000 $0 Available LIne S750,000 I Enroll Connpaq Eli Lilly liOLI TCW 100.0% $1,000,000 $0 S 1,000,000 I 100.0% $500,000 $0 $500,000 100.0% $0 $0 $2,250,000 $1) so I $2,250,000 I * ('otn pass LOC has .!l0% Liv on all liquid assets held as collateral; tine escejnio'e as Me Sanders~ acco tout which co,asasts of ulliquid assets that compass offers the lesser of 30% L1J' on) mm I.OC 0109414 HI8t2W12 C c~. U- 0.-f -g Allocatiota of Collateral for Secured LOC VA Chase Costa aSs' lU 68.3% 93.2% 72.6% 31.7% 6.8% 0.0% 0.0% 00% 27.4% diversilied 00% 00% 0.0% 0.0% 0.0% 0 ($1. Collateral Valuation Bank of Amertca Stock Price assumptions 4-Sep-01 Enron S35.00 TCW - Select 515.25 Compaq SILOS TCW-Aggr. 31144 Eli Lilly $78.72 TCW. Small 317.60 EOTT $19.99 Outstanding Loan Balance S5.579.392 Collateral Pled ed Shares Value Enron Corp. 226,445 57,925.575 Compaq Computer 332.256 ~~j396 Total Market Value of Collateral Si 1.606.971 Less: Collateral Required (80% LTV) 48.07% S6,974.240 Outstanding Loan Balance S6.973.000 Collateral Pledged Shares Value Compaq 113,064 5 1.252,749 Eli Lilly & Co. 20,220 31.591,718 EOT'r Energy Partners 5,000 S99,950 TCW Galileo Select Equities 131,738 32.009.005 TCW Galileo Ag~essive Growth 37,949 $434,137 TCW Small Cap Growth 41,485 3730,136 Enron Corp. (includes additional 25,000 shares) 60.000 j~j.g0 000 Total Market Value of Collateral SS.217,695 Less: Collateral Required (LTV 80%) 84.85% 38,716.250 Excess (Deficit) Collateral S498.555) Borrowing Power SO Available to Borrow $0 LAY-SEC-I. 000000245 Congnjenual Treament Requcited unUer POIA 68.3% 31.7% 100.0% 15.2% 19,4% 1.2% 24.4% 5.3% 8.9% 25.6% 100.0% Loco1o9o4 8/5/2002 Collateral Valuation Bank of America 0 e3 ~OBi~ 110 Outstanding Loan Balance SS.OOO.OOO Collateral Pledged Shares Value Enron Corp. 193.130 S6,759.$5O Compaq Computer SO Total Marker Value of Collateral S6,759.5S0 Less: Collateral Required (800/c LTY) 74.0% S6.250.O00 Excess (Deficit) Collateral S509..550 Borrowing Power S407.640 Available to Borrow 5407.640 5750.000 Line of Credit (Unsecured) [/N/O Kenneth L. & Linda P. Lay Outstanding Loan Balance WC..0t0904 8/8/2002 LAY-SEC-i 000000246 so conrden~S~ I re3fl'~"~ Requesteli updtf VOIA 10000 Collateral Valuation Chase 4-Sep-01 ~Swck Price Assumptions Enron 535.00 Comoao 511.08 S 15.0 Million Non P'~ose Credit Line Symbol CeniC. No. Enron Corp ENE Enron Corp ENE Compaq Chase Acct Chase Acct Total ENE Shares Value Ownership 3.936 S.388 86,324 S l3~60 S S 3,021.340 Personal Personal CPQ BB125523 ,Q~0 S 22 1.600 Personal Total CPQ 20,000 S 221.600 6.8% Total Value or Collateral S 3.242.940 LTV 800/0 AVAILABLE BALANCE S2.432.205~~ Funded (S2.689;000) REMAINING BALANCE . (S256,795j LOC..0 10904 8/8/2002 LAY-S EC- I. 000000247 ( unfidn~tial Treanieni 3J.egue~ied under FOIA Collateral Valuation Compass 4-Sep-01 Stock price Assumption Enron 335.00 Eli Lilly 378.72 S 10.0 Million Non Purpose Credit Line STOCK Symbol Certit. No. Shares Ownership Eli Lilly LLY FC24922 5000 Personal Eli Lilly LLY CNY18380 5.000 Personal Total LLY 10,000 787.200 Enron Corp ENE HC119322 7.690 Personal Enron Corp ENE HC119285 22.052 Personal Enron Corp ENE HC119286 1.751 Personal Enron Corp-Split ENE HC164652 1,751 Personal Enron Corp ENE HC119359 4,521 Personal Enron Corp-Split ENE HC164653 4,521 Personal Enron Corp ENE HC119360 7,792 Personal Enron Corp ENE HC127094 9 ~-40 Personal Total ENE 59.518 2.083.130 TOTAL $ 2,870,330 LTV 80% AVAILABLE BALANCE 52.296.264 Funded (S3.489.871~ REMAINING BALANCE (51.193.607) Additional Collateral Sanders Moms Hams (30% LTV. caoped at 51.000,000) Total S 3.500,000 LTV 300/. AVAILABLE BALANCE $ 1,000,000 Funded.~«=.S0~ REMAINiNG BALANCE 51.000.000 qrnfnjrntial 1 reament HnwCsted under FOIA LAY~SEC..l 000000248 27 4% 72.6% L0C01 0~04 S/B! 2002 Personal - Secured LOC ($000) Enron LOC Pw BA Chase Compass Total 500 3.706 (118) (194) 3.894 Personal - Unsecured LOC ($000) BA 1,000 Chase 1,000 Compass 500 Total 2,500 Partnership - LOC ($000) Now BAa Pw 9 (increasing from $750,000; should be effective next week) (increasing from $750,000; should be effective next week) 257 (additional collateral should be in place early next week) waiting for the dust to clear but it is positive 257 at least this much When shares settle at BA assuming yesterdays price of $48.34 BA (499) PW 9 (499) LAY~SEC..l 000000249 Confidenual Treameng Requested under FOKA 500,000 9,146,000 1,900,000 400,000